This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02691/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02691/identifier/kegg-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02691/identifier/pubchem-compound/
n16http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB02691/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB02691/identifier/drugbank/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02691/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB02691/identifier/chebi/

Statements

Subject Item
n2:DB02691
rdf:type
n6:Drug
n6:description
The glycine conjugate of cholic acid. It acts as a detergent to solubilize fats for absorption and is itself absorbed. [PubChem]
n6:group
experimental
owl:sameAs
n4:DB02691 n16:DB02691
dcterms:title
N-Cholylglycine
adms:identifier
n9:735 n10:DB02691 n11:29746 n12:46936456 n13:46507924 n14:C01921 n15:GCH
n6:IUPAC-Name
n7:271B4F37-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B4F3D-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B4F3C-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B4F39-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B4F3A-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B4F3B-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B4F35-363D-11E5-9242-09173F13E4C5 n7:271B4F4D-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B4F36-363D-11E5-9242-09173F13E4C5 n7:271B4F33-363D-11E5-9242-09173F13E4C5 n7:271B4F4F-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B4F34-363D-11E5-9242-09173F13E4C5 n7:271B4F50-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B4F43-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B4F44-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B4F3E-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B4F3F-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B4F41-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B4F40-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B4F42-363D-11E5-9242-09173F13E4C5
n6:casRegistryNumber
475-31-0
n6:Bioavailability
n7:271B4F49-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B4F4B-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B4F4C-363D-11E5-9242-09173F13E4C5
n6:Melting-Point
n7:271B4F4E-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B4F48-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B4F47-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B4F4A-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B4F38-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B4F45-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B4F46-363D-11E5-9242-09173F13E4C5